A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated
Clinical trial NCT05469646 · COMPLETED
Trial details
- NCT number
- NCT05469646
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2022-12-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.